North China’s Shanxi province is currently home to nine companies producing protective masks for control and prevention of the novel coronavirus pneumonia — with a daily production capacity of 300,000, according to the Shanxi Industry and Information Technology Department.
Before the outbreak of the epidemic, there were no mask manufacturing companies in Shanxi and no related manufacturing companies, officials said.
Targeting the difficulties of enterprises in raw materials, capital, and employee training, the Shanxi Industry and Information Technology Department rolled out measures to promote protective mask production.
The department issued a special reward plan for key emergency medical suppliers for coronavirus pneumonia prevention and control.
It invested 50 million yuan ($7.17 million) in technological transformation funds, which were specifically used for subsidies and rewards for the production of protection products.
Another 20 million yuan in funds were allocated to pharmaceutical logistics enterprises, to ensure the smooth collection and storage of protective masks in Shanxi province.
The department also liaised with key manufacturers and China Development Bank, to help the companies secure financial support.
As an example, Sinopharm Holding Shanxi Co, a subsidiary of Sinopharm Group in Shanxi province, is accelerating the building of factories.
A spokesman said that once all 12 production lines of the company went into operation, the production and supply capacity of protective masks in Shanxi would be greatly improved.